Kepivance 66658-0113

Generic: Palifermin

Product NDC

66658-0113

Manufacturer: Swedish Orphan Biovitrum Ab (publ)
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: August 4, 2023
Listing Expires: December 31, 2026
Application: BLA125103

Need to source Kepivance? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Palifermin	5.16 mg/1.2mL

Drug Class

Mucocutaneous Epithelial Cell Growth Factor [EPC]Fibroblast Growth Factor 7 [CS]Increased Epithelial Proliferation [PE]

Packaging Options(1)

66658-0113-03

3 VIAL, SINGLE-USE in 1 CARTON (66658-113-03) / 1.2 mL in 1 VIAL, SINGLE-USE (66658-113-01)

View →